Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Published in: Inflammation Research 11/2005

01-11-2005 | Original Research Paper

Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1)

Authors: M. N. Svendsen, K. Werther, I. J. Christensen, L. Basse, H. J. Nielsen

Published in: Inflammation Research | Issue 11/2005

Login to get access
Metadata
Title
Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1)
Authors
M. N. Svendsen
K. Werther
I. J. Christensen
L. Basse
H. J. Nielsen
Publication date
01-11-2005
Publisher
Birkhäuser-Verlag
Published in
Inflammation Research / Issue 11/2005
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-005-1376-3

Other articles of this Issue 11/2005

Inflammation Research 11/2005 Go to the issue

Original Research Paper

Effect and mechanisms of FR167653, a dual inhibitor of TNF-α and IL-1, on BCG plus LPS induced-liver injury

Original Research Paper

LBP inhibitory peptide reduces endotoxin-induced macrophage activation and mortality

Review

A heretofore undisclosed crux of Eosinophilia-Myalgia Syndrome: compromised histamine degradation

Original Research Paper

Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits